Annual CFO
-$8.13 M
+$3.30 M+28.87%
December 31, 2022
Summary
- As of February 8, 2025, SCPS annual cash flow from operations is -$8.13 million, with the most recent change of +$3.30 million (+28.87%) on December 31, 2022.
- During the last 3 years, SCPS annual CFO has fallen by -$6.01 million (-283.26%).
- SCPS annual CFO is now -987.46% below its all-time high of -$747.30 thousand, reached on December 31, 2018.
Performance
SCPS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.01 M
-$249.30 K-32.81%
June 30, 2023
Summary
- As of February 8, 2025, SCPS quarterly cash flow from operations is -$1.01 million, with the most recent change of -$249.30 thousand (-32.81%) on June 30, 2023.
- Over the past year, SCPS quarterly CFO has dropped by -$157.50 thousand (-18.49%).
- SCPS quarterly CFO is now -803.49% below its all-time high of -$111.70 thousand, reached on June 30, 2018.
Performance
SCPS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$3.04 M
+$1.87 M+38.02%
June 30, 2023
Summary
- As of February 8, 2025, SCPS TTM cash flow from operations is -$3.04 million, with the most recent change of +$1.87 million (+38.02%) on June 30, 2023.
- Over the past year, SCPS TTM CFO has increased by +$8.81 million (+74.33%).
- SCPS TTM CFO is now -1342.72% below its all-time high of -$210.90 thousand, reached on March 1, 2018.
Performance
SCPS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SCPS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.9% | -18.5% | +74.3% |
| 3 y3 years | -283.3% | -23.3% | -41.4% |
| 5 y5 years | - | -803.5% | -43.5% |
SCPS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.9% | -139.2% | +75.7% | at high | +77.5% |
| 5 y | 5-year | -283.3% | +28.9% | -696.5% | +75.7% | -55.3% | +77.5% |
| alltime | all time | -987.5% | +28.9% | -803.5% | +75.7% | -1342.7% | +77.5% |
Scopus BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$1.01 M(+32.8%) | -$3.04 M(-38.0%) |
| Mar 2023 | - | -$759.90 K(+80.1%) | -$4.91 M(-39.6%) |
| Dec 2022 | -$8.13 M(-28.9%) | -$421.90 K(-50.5%) | -$8.13 M(-31.4%) |
| Sep 2022 | - | -$851.70 K(-70.4%) | -$11.85 M(-12.3%) |
| Jun 2022 | - | -$2.88 M(-27.7%) | -$13.52 M(+7.2%) |
| Mar 2022 | - | -$3.98 M(-4.1%) | -$12.61 M(+10.3%) |
| Dec 2021 | -$11.42 M(+352.4%) | -$4.15 M(+64.8%) | -$11.42 M(+39.4%) |
| Sep 2021 | - | -$2.52 M(+28.3%) | -$8.20 M(+29.3%) |
| Jun 2021 | - | -$1.96 M(-29.8%) | -$6.34 M(+22.0%) |
| Mar 2021 | - | -$2.80 M(+204.2%) | -$5.20 M(+105.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$2.53 M(+19.1%) | -$919.30 K(+39.1%) | -$2.53 M(+14.2%) |
| Sep 2020 | - | -$661.10 K(-19.2%) | -$2.21 M(+2.8%) |
| Jun 2020 | - | -$818.20 K(+545.8%) | -$2.15 M(+9.9%) |
| Mar 2020 | - | -$126.70 K(-79.1%) | -$1.96 M(-7.6%) |
| Dec 2019 | -$2.12 M(+183.7%) | -$605.70 K(+0.7%) | -$2.12 M(+40.0%) |
| Sep 2019 | - | -$601.70 K(-3.7%) | -$1.51 M(+65.9%) |
| Jun 2019 | - | -$624.70 K(+116.7%) | -$913.00 K(+128.3%) |
| Mar 2019 | - | -$288.30 K(+158.1%) | -$400.00 K(+24.0%) |
| Dec 2018 | -$747.30 K | - | - |
| Jun 2018 | - | -$111.70 K(-47.0%) | -$322.60 K(+53.0%) |
| Mar 2018 | - | -$210.90 K | -$210.90 K |
FAQ
- What is Scopus BioPharma annual cash flow from operations?
- What is the all time high annual CFO for Scopus BioPharma?
- What is Scopus BioPharma annual CFO year-on-year change?
- What is Scopus BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Scopus BioPharma?
- What is Scopus BioPharma quarterly CFO year-on-year change?
- What is Scopus BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for Scopus BioPharma?
- What is Scopus BioPharma TTM CFO year-on-year change?
What is Scopus BioPharma annual cash flow from operations?
The current annual CFO of SCPS is -$8.13 M
What is the all time high annual CFO for Scopus BioPharma?
Scopus BioPharma all-time high annual cash flow from operations is -$747.30 K
What is Scopus BioPharma annual CFO year-on-year change?
Over the past year, SCPS annual cash flow from operations has changed by +$3.30 M (+28.87%)
What is Scopus BioPharma quarterly cash flow from operations?
The current quarterly CFO of SCPS is -$1.01 M
What is the all time high quarterly CFO for Scopus BioPharma?
Scopus BioPharma all-time high quarterly cash flow from operations is -$111.70 K
What is Scopus BioPharma quarterly CFO year-on-year change?
Over the past year, SCPS quarterly cash flow from operations has changed by -$157.50 K (-18.49%)
What is Scopus BioPharma TTM cash flow from operations?
The current TTM CFO of SCPS is -$3.04 M
What is the all time high TTM CFO for Scopus BioPharma?
Scopus BioPharma all-time high TTM cash flow from operations is -$210.90 K
What is Scopus BioPharma TTM CFO year-on-year change?
Over the past year, SCPS TTM cash flow from operations has changed by +$8.81 M (+74.33%)